Vitamin K2 Market

Vitamin K2 Market Size, Share, Growth Analysis, By Function (Bone and Cardiovascular Health, Blood Health and Clotting), By Product Type (MK-4, MK-7), By Form, By Source, By Application, By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2355 | Region: Global | Published Date: November, 2024
Pages: 160 | Tables: 88 | Figures: 71

Vitamin K2 Market News

  • In March 2024, SunWay Biotech and Gnosis by Lesaffre have introduced MenaQ7 Metabolic, a vitamin K2 blend with statin-free red yeast rice fermentate Ankascin 568-R for heart and bone health. With over 130 studies confirming its benefits to metabolism, this new ingredient has just obtained a certification of NDI and is Monacolin K-free.
  • In April 2023, Kappa Bioscience is renowned for manufacturing vitamin K2 under the flagship brand K2VITAL, and it will showcase, for the first time at Vitafoods Europe, the combined benefits of the all-trans vitamin K2 MK-7 ingredients along with the wide-ranging products from the Balchem Human Nutrition & Health portfolio.
  • In June 2022, the deal with Kappa Bioscience, the market-leading manufacturer of vitamin K2, by Balchem Corp. was one intended to be finalized. This calculated agreement was within Balchem's goal of encouraging health and wellbeing. Devoted to developing better health solutions revolving around vitamin K2, Kappa Bioscience aims to improve the quality of life for people.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Vitamin K2 Market size was valued at USD 142 million in 2022 and is poised to grow from USD 161.74 million in 2023 to USD 458.14 million by 2031, growing at a CAGR of 13.90% during the forecast period (2024-2031).

The Vitamin K2 Market is highly fragmented with the presence of major key players within the sector. Prominent entities in the vitamin K2 market, including NOW Foods, Seebio Biotech, Gnosis SpA, implementing diverse strategies to fortify their market position and expand the scope of their offerings. Partnerships and expansion initiatives are among the primary strategies driving the market's growth. 'AlloSource (US) ', 'Smith + Nephew (UK) ', 'Medtronic (Ireland) ', 'Orthofix US LLC (US) ', 'Zimmer Biomet (US) ', 'Geistlich Pharma AG (Switzerland) ', 'Stryker (US) ', 'Biobank (UK) ', 'DSM Nutritional Products (Switzerland) ', 'Pharmavit (India) ', 'Viridis BioPharma Pvt. Ltd. (India) ', 'Lactonova Nutripharm Pvt. Ltd. (India) ', 'Gencor Pacific Inc. (US) ', 'NuScience Trading, LLC (US) ', 'NutriScience Innovations LLC (US) ', 'ExcelVite Sdn. Bhd. (Malaysia) ', 'Parchem Fine & Specialty Chemicals (US) ', 'Avanscure Lifesciences Pvt. Ltd. (India) ', 'Health Thru Nutrition (US) ', 'Ampak Company, Inc. (US) ', 'Arnet Pharmaceutical (US) ', 'Swanson Health Products (US) ', 'AIDP, Inc. (US) ', 'Ortho Molecular Products (US) ', 'Evesa Nutritionals (India)'

Increased Awareness of Bone Health

Rising Interest in Functional Foods: The rising interest in functional foods is hugely influencing the vitamin K2 market. Growing numbers of consumers are in search of those meals that can provide more health benefits than just plain nutrition. This trend is driving the addition of Vitamin K2 to a range of functional meals, ranging from plant-based replacements to nutritious bars to strengthened dairy products. The addition of vitamin K2 to such common products by producers is the response to demand for chemicals which improve health. This emphasis on functional foods is a part of a greater wellness trend, one which will increase both the vitamin K2 market and its availability to health-conscious consumers.

Asia Pacific dominated vitamin K2 during 2024-2030, with the highest market share of 36.3%. The rising middle-class population with higher disposable resources and increasing awareness regarding nutritional supplements for maintaining overall health, are factors to consider in the region. For instance, countries such as South Korea and Japan have a culture mainly based on traditional medicines; this leads to them consuming huge amounts of products that are combined with vitamin K2. With better technology for the manufacturing process nowadays, such supplements can be afforded on all economic levels of customers. Regarding demands from industry and recognition of the popular uses of the vitamin in dietary health supplements, in December 2023, MFDS South Korea proposed licensing of vitamin K2 as a health functional food component. A minister, Oh Yu-Kyoung, visited the regional producer GF-Fermentech, which is an indication that the ministry is taking serious efforts to examine this component.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Vitamin K2 Market

Report ID: SQMIG35I2355

$5,300
BUY NOW GET FREE SAMPLE